Used in research as a selective agonist for the nuclear receptor NR4A1 (also known as Nur77), C-DIM12 is investigated for its potential anticancer properties. It has shown activity in inducing apoptosis in various cancer cell lines, particularly in prostate and colon cancer models. The compound also demonstrates anti-inflammatory effects by modulating signaling pathways such as NF-κB. Additionally, it is used as a tool compound to study mitochondrial function and metabolic regulation in cellular models. Its ability to cross the blood-brain barrier makes it relevant in neurodegenerative disease research.